Efficacy of Tirzepatide for Weight Loss in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of Tirzepatide for Weight Loss in China

Published:2024-08-20 Issue:7 Volume:332 Page:538
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Qian Frank¹,Hu Frank B.²³⁴

Affiliation:

1. Section of Cardiovascular Medicine, Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts

2. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

3. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

4. Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jama/articlepdf/2819437/jama_qian_2024_ed_240036_1723483088.74309.pdf

Reference16 articles.

1. Update on the obesity epidemic: after the sudden rise, is the upward trajectory beginning to flatten?;Koliaki;Curr Obes Rep,2023

2. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.;NCD Risk Factor Collaboration (NCD-RisC);Lancet,2024

3. Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits.;Drucker;Diabetes Care,2010

4. GLP-1 receptor agonists in the treatment of type 2 diabetes—state-of-the-art.;Nauck;Mol Metab,2021

5. Tirzepatide once weekly for the treatment of obesity.;Jastreboff;N Engl J Med,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP